Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 4, 2005, Pages 701-708

  Izzo, Emanuela ^a,b   Sanna, Pietro Paolo ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Newron Pharmaceuticals   (Italy)

Author keywords

Amphetamine stereotypy; Catalepsy; Chronic stress; CRF; Dopamine; Oxidative stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMPHETAMINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ETICLOPRIDE; MALONALDEHYDE; MARKER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR; BRAIN LEVEL; BRAIN REGION; BRAIN TISSUE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; LIPID PEROXIDATION; MALE; MEASUREMENT; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STEREOTYPY; STRESS;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CATALEPSY; CORPUS STRIATUM; CORTICOTROPIN-RELEASING HORMONE; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; STEREOTYPED BEHAVIOR; TIME FACTORS;

ANIMALIA;

EID: 23944513487     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.04.017     Document Type: Article

References (34)

1. M. Amalric, and G.F. Koob Depletion of dopamine in the caudate nucleus but not nucleus accumbens impairs reaction-time performance in rats J Neurosci 7 1987 2129 2134
2. M. Amalric, and G.F. Koob Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system G.W. Arbuthnott P.C. Emson Chemical signalling in the basal ganglia Progress in Brain Research vol. 99 1993 Elsevier New York 209 226
3. D.E. Barnes, B. Robinson, J.G. Csernansky, and E.P. Bellows Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants Pharmacol Biochem Behav 36 1990 883 887
4. M.F. Beal Mitochondria, free radicals, and neurodegeneration Curr Opin Neurobiol 6 1996 661 666
5. J.D. Bremner Does stress damage the brain? Biol Psychiatry 45 1999 797 805
6. S.L. Castro, and M.J. Zigmond Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-d-aspartate receptors in substantia nigra Brain Res 901 2001 47 54
7. B.J. Cole, and G.F. Koob Low doses of corticotropin-releasing factor potentiate amphetamine-induced stereotyped behavior Psychopharmacology 99 1989 27 33
8. I. Creese, and S.D. Iversen Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine Brain Res 55 1973 369 382
9. P.R. Dickson, C.G. Lang, S.C. Hinton, and A.E. Kelley Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study Neuroscience 61 1994 81 91
10. B. Dubois, and B. Pillon Cognitive deficits in Parkinson's disease J Neurol 244 1997 2 8
11. A.J. Dunn, and C.W. Berridge Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15 1990 71 100
12. E.F. Espejo, and J. Minano Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion J Neurophysiol 85 2001 1270 1274
13. H.C. Fibiger Neurobiology of depression: focus on dopamine G.L. Gessa Depression and mania: from neurobiology to treatment Advances in Biochemical Psychopharmacology vol. 49 1995 Raven Press New York 1 17
14. J.M. Finlay, and M.J. Zigmond The effects of stress on central dopaminergic neurons: possible clinical implications Neurochem Res 22 1997 1387 1394
15. P.J. Gresch, A.F. Sved, M.J. Zigmond, and J.M. Finlay Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat J Neurochem 63 1994 575 583
16. B.A. Horger, and R.H. Roth The role of mesoprefrontal dopamine neurons in stress Crit Rev Neurobiol 10 1996 395 418
17. J. Kulisevsky Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease Drugs Aging 16 2000 365 379
18. S. Kullback Information theory and statistics 1968 Dover New York
19. J. Liu, H.C. Yeo, E. Overvik-Douki, T. Hagen, S.J. Doniger, and D.W. Chu Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants J Appl Physiol 89 2000 21 28
20. J.L. Madrigal, R. Olivenza, M.A. Moro, I. Lizasoain, P. Lorenzo, and J. Rodrigo Glutathione depletion, lipid peroxidation and mithocondrial dysfunction are induced by chronic stress in rat brain Neuropsychopharmacology 24 2001 420 429
21. V.S. Mattay, A. Tessitore, J.H. Callicott, A. Bertolino, T.E. Goldberg, and T.N. Chase Dopaminergic modulation of cortical function in patients with Parkinson's disease Ann Neurol 51 2002 156 164
22. K. Mizoguchi, M. Yuzurihara, A. Ishige, H. Sasaki, D.H. Chui, and T. Tabira Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction J Neurosci 20 2000 1568 1574
23. P. Moller, H. Wallin, and L.E. Knudsen Oxidative stress associated with exercise, psychological stress and life-style factors Chem Biol Interact 102 1996 17 36
24. L. Pani, A. Porcella, and G.L. Gessa The role of stress in the pathophysiology of the dopaminergic system Mol Psychiatry 5 2000 14 21
25. M. Papp, R. Muscat, and P. Willner Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress Psychopharmacology 110 1993 152 158
26. M. Papp, V. Klimek, and P. Willner Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine Psychopharmacology 115 1994 441 446
27. L.J. Pellegrino, A.J. Pellegrino, and A.J. Cushman A stereotaxic atlas of the rat brain 1979 Plenum Press New York
28. L. Pulvirenti, and G.F. Koob Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats Neuropsychopharmacology 8 1993 213 218
29. J. Rivier, J. Spiess, and W. Vale Characterization of rat hypothalamic corticotropin-releasing factor Proc Natl Acad Sci U S A 80 1983 4851 4855
30. T.W. Robbins A critique of the methods available for the measurement of spontaneous motor activity L.L. Iversen S.D. Iversen S.H. Snyder Principles of behavioral pharmacology Handbook of Psychopharmacology vol. 7 1977 Plenum Press New York 37 82
31. J.S. Schneider, and A. Pope-Coleman Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey Neurodegeneration 4 1995 245 255
32. H. Simon, K. Taghzouti, H. Gozlan, J.M. Studler, A. Louilot, and D. Herve Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens Brain Res 447 1988 335 340
33. A.H. Stokes, T.G. Hastings, and K.E. Vrana Cytotoxic and genotoxic potential of dopamine J Neurosci Res 55 1999 659 665
34. P. Willner, R. Muscat, and G. Phillips The role of dopamine in rewarded behavior: ability, insight, drive or incentive? Pol J Pharmacol Pharm 43 1991 291 300